Literature DB >> 24268966

Malignant epithelioid hemangioendothelioma of the lip: a case report and comprehensive literature review.

Allen A Robinson1, Lucilene F Tolentino2, Jettie Uyanne3, Raymond Melrose4, Colonya C Calhoun5.   

Abstract

Malignant epithelioid hemangioendothelioma (MEH), also known as high-risk epithelioid hemangioendothelioma, is a low- to intermediate-grade vascular malignancy originally described as a vascular neoplasm of endothelial origin. This very rare vascular neoplasm has been described mainly in soft tissue, but also in various organs and locations, including the liver, lung, brain, colon, lymph nodes, peritoneum, spleen, bone, skin, heart, soft tissues, and vascular system. Several cases have been described in the head and neck, including the submandibular gland, parotid gland, nasal cavity, parapharyngeal space, maxilla, maxillary sinus, occipital bone, oral cavity, thyroid gland, neck, scalp, larynx, and mandible. This case report is the first description of MEH presenting as an exophytic lower-lip lesion. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2013        PMID: 24268966     DOI: 10.1016/j.joms.2013.09.027

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  3 in total

Review 1.  A rare case of intravascular epithelioid hemangioendothelioma of the cephalic vein treated with surgery and postoperative radiation therapy: a case report and review of the literature.

Authors:  Maria Paola Ciliberti; Raffaella Caponio; Antonio Pascali; Gabriele Matichecchia; Marco Lioce
Journal:  J Med Case Rep       Date:  2015-04-29

2.  Clinicopathological characteristics of pulmonary epithelioid hemangioendothelioma: A report of four cases and review of the literature.

Authors:  Jinchen Shao; Jie Zhang
Journal:  Oncol Lett       Date:  2014-09-26       Impact factor: 2.967

3.  Maxillary epithelioid hemangioendothelioma: an especially rare malignant tumor mimicking periodontal disease.

Authors:  Gintaras Januzis; Dovydas Sakalys; Martynas Mantas Krukis; Dmitrij Seinin
Journal:  BMC Oral Health       Date:  2020-11-06       Impact factor: 2.757

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.